XML 61 R33.htm IDEA: XBRL DOCUMENT v3.22.4
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)
12 Months Ended
Sep. 30, 2022
FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS  
Schedule of estimate of fair value of the Company's warrants issued and outstanding The assumptions used that represent management’s best estimates of the fair value of the Company’s warrants and other convertible instruments issued and outstanding were as follows:

    

September 30, 2022

 

Expected term (in years)

 

4.75 - 9.97

Volatility

 

152 %

Dividend yield

 

0.00 %

Risk-free interest rate

 

2.98 - 3.01 %

Exercise price

 

$

8.83